garenoxacin has been researched along with gamma-aminobutyric acid in 1 studies
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
| Studies (garenoxacin) | Trials (garenoxacin) | Recent Studies (post-2010) (garenoxacin) | Studies (gamma-aminobutyric acid) | Trials (gamma-aminobutyric acid) | Recent Studies (post-2010) (gamma-aminobutyric acid) |
|---|---|---|---|---|---|
| 195 | 19 | 46 | 40,215 | 1,423 | 9,631 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, H; Kawamura, Y; Morita, Y; Nakamura, T; Soumi, K | 1 |
1 other study(ies) available for garenoxacin and gamma-aminobutyric acid
| Article | Year |
|---|---|
Pharmacological evaluation of garenoxacin, a novel des-F(6)-quinolone antimicrobial agent: effects on the central nervous system.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Central Nervous System; Drug Interactions; Fluoroquinolones; gamma-Aminobutyric Acid; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Models, Animal; Quinolones; Rats; Rats, Wistar; Receptors, GABA; Seizures | 2003 |